Immediate Impact

1 from Science/Nature 44 standout
Sub-graph 1 of 22

Citing Papers

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
2025 Standout
The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia
2024 Standout
2 intermediate papers

Works of Joshua Noone being referenced

86-LB: Real-World Effectiveness of Oral Semaglutide (OS) from a U.S. Commercially Insured and Medicare Advantage Population
2021
Cachexia among US cancer patients
2016

Author Peers

Author Last Decade Papers Cites
Joshua Noone 16 115 31 131 53 21 450
Yongjian Qi 5 24 40 77 104 24 484
Guozhen Liu 5 28 9 75 47 21 439
Kiarash Tanha 22 92 12 34 53 31 494
Alberto Frisoli 25 261 12 162 39 19 485
Laura J. Hoeksema 9 60 21 105 40 14 379
Soyeun Kim 74 90 13 67 38 16 419
Gavriela Voulgaridou 9 267 14 77 51 32 444
Maryam Ghodsi 128 48 16 34 98 31 441
Şansın Tüzün 10 84 8 202 48 26 451
Sarah L. Morgan 1 152 12 64 52 23 400

All Works

Loading papers...

Rankless by CCL
2026